Scarica l'app Stockscreener
84.98
1.47%
1.23
Pre-mercato:
85.57
0.59
+0.69%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$83.75
Aprire:
$83.64
Volume 24 ore:
1.95M
Relative Volume:
0.85
Capitalizzazione di mercato:
$16.44B
Reddito:
$8.41B
Utile/perdita netta:
$760.80M
Rapporto P/E:
22.07
EPS:
3.8513
Flusso di cassa netto:
$1.05B
1 W Prestazione:
+2.93%
1M Prestazione:
+2.51%
6M Prestazione:
-8.72%
1 anno Prestazione:
-7.48%
Intervallo 1D:
$83.51
$85.60
Intervallo di 1 settimana:
$81.58
$85.60
Portata 52W:
$79.12
$108.29
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Nome
Zimmer Biomet Holdings Inc
Settore
Industria
Telefono
(574) 267-6131
Indirizzo
345 EAST MAIN STREET, WARSAW, IN
Compare ZBH vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
84.98 | 16.20B | 8.41B | 760.80M | 1.05B | 3.8513 |
ABT
Abbott Laboratories
|
86.99 | 151.49B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.00 | 112.44B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
77.95 | 94.69B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
47.69 | 70.87B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.00 | 50.47B | 6.30B | 1.07B | 1.09B | 1.8406 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-23 | Downgrade | BTIG Research | Buy → Neutral |
| 2026-02-20 | Iniziato | William Blair | Mkt Perform |
| 2026-01-09 | Downgrade | Goldman | Neutral → Sell |
| 2026-01-06 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2026-01-05 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-12-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-11-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-09-18 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-07-15 | Aggiornamento | Roth Capital | Neutral → Buy |
| 2024-12-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2024-09-10 | Iniziato | Wolfe Research | Peer Perform |
| 2024-07-01 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-21 | Aggiornamento | Argus | Hold → Buy |
| 2024-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-10-20 | Iniziato | ROTH MKM | Neutral |
| 2023-08-28 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2023-05-03 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-04-11 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-03-31 | Aggiornamento | Jefferies | Underperform → Hold |
| 2023-03-29 | Iniziato | UBS | Sell |
| 2023-03-10 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Iniziato | Barclays | Underweight |
| 2022-10-12 | Iniziato | Jefferies | Underperform |
| 2022-05-27 | Downgrade | Needham | Buy → Hold |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2022-04-01 | Downgrade | Citigroup | Buy → Neutral |
| 2022-03-02 | Ripresa | BofA Securities | Underperform |
| 2022-03-02 | Downgrade | Loop Capital | Buy → Hold |
| 2022-02-08 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | Reiterato | Citigroup | Buy |
| 2022-02-08 | Reiterato | Deutsche Bank | Hold |
| 2022-02-08 | Reiterato | JMP Securities | Mkt Outperform |
| 2022-02-08 | Reiterato | JP Morgan | Neutral |
| 2022-02-08 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | Reiterato | Stifel | Buy |
| 2022-02-08 | Reiterato | Truist | Buy |
| 2022-02-08 | Reiterato | UBS | Neutral |
| 2022-02-08 | Reiterato | Wells Fargo | Underweight |
| 2022-02-02 | Downgrade | UBS | Buy → Neutral |
| 2022-01-19 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | Downgrade | Mizuho | Buy → Neutral |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | Downgrade | Needham | Strong Buy → Buy |
| 2021-12-07 | Iniziato | Loop Capital | Buy |
| 2021-11-23 | Downgrade | Argus | Buy → Hold |
| 2021-09-14 | Ripresa | Raymond James | Mkt Perform |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-09 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-12-18 | Reiterato | Needham | Strong Buy |
| 2020-10-20 | Iniziato | Northland Capital | Market Perform |
| 2020-09-11 | Iniziato | Wolfe Research | Outperform |
| 2020-08-05 | Reiterato | Needham | Strong Buy |
| 2020-04-28 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-04-09 | Downgrade | Evercore ISI | Outperform → In-line |
| 2020-04-07 | Reiterato | Needham | Strong Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2020-01-07 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2019-09-18 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | Aggiornamento | Argus | Hold → Buy |
| 2019-07-30 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2019-07-29 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | Aggiornamento | Needham | Buy → Strong Buy |
Mostra tutto
Zimmer Biomet Holdings Inc Borsa (ZBH) Ultime notizie
Zimmer Biomet (NYSE: ZBH) officer receives 1,857 RSU equity award - Stock Titan
Wells Fargo Gives a Hold Rating to Zimmer Biomet Holdings (ZBH) - The Globe and Mail
Wound Irrigation Systems Market to Skyrocket USD 430.05 Million by 2035 as Chronic Wound Cases and Surgical Volumes Rise Worldwide | SNS Insider - GlobeNewswire Inc.
Zimmer Biomet group president Yi Sang sells $413,216 in stock By Investing.com - Investing.com Canada
Zimmer Biomet group president Yi Sang sells $413,216 in stock - Investing.com
ZIMMER BIOMET (ZBH) Asia Pacific president sells 5,000 shares in open market - Stock Titan
Zimmer Biomet to Present at the Goldman Sachs 47th Annual Global Healthcare Conference - PR Newswire
Thompson Siegel & Walmsley LLC Sells 76,365 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings, Inc. (ZBH): Investor Outlook With A 19.88% Potential Upside - DirectorsTalk Interviews
Geode Capital Management LLC Increases Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Grandfield & Dodd LLC Cuts Stock Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer (ZBH) up 3.1% since last earnings report: Can it continue? - MSN
[144] ZIMMER BIOMET HOLDINGS, INC. SEC Filing - Stock Titan
United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund Acquires New Shares in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Legal & General Group Plc Has $137.94 Million Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings Is Maintained at Neutral by Citigroup - Moomoo
ZBH Technical Analysis | Trend, Signals & Chart Patterns | ZIMMER BIOMET HOLDINGS INC (NYSE:ZBH) - ChartMill
Citigroup Has Lowered Expectations for Zimmer Biomet (NYSE:ZBH) Stock Price - MarketBeat
Goldman Sachs Adjusts PT on Zimmer Biomet to $87 From $86, Maintains Sell Rating - Moomoo
Zimmer (ZBH) Up 3.1% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Citigroup Adjusts Price Target on Zimmer Biomet to $93 From $95, Maintains Neutral Rating - marketscreener.com
Zimmer Biomet 8-K Filing May 22, 2026: NYSE Registered Securities, Entity Information, and Amendment Details - Minichart
Zimmer Biomet Holdings (ZBH) Announces Results of Annual Shareho - GuruFocus
Zimmer Biomet Shareholders Reaffirm Board, Leadership and Oversight - TipRanks
Zimmer Biomet (ZBH) investors approve board slate and pay, reject independent chair bid - Stock Titan
Declaration of Voting Results by Zimmer Biomet - marketscreener.com
Zimmer Biomet Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Zimmer Biomet (NYSE: ZBH) director receives new RSU and phantom unit awards - Stock Titan
Zimmer Biomet (NYSE: ZBH) director receives new RSU and phantom unit grants - Stock Titan
Zimmer Biomet (NYSE: ZBH) director awarded RSU and phantom stock units - Stock Titan
Zimmer Biomet (NYSE: ZBH) director granted Restricted and Phantom Stock Units - Stock Titan
Zimmer Biomet (NYSE: ZBH) director granted RSUs and phantom stock units as compensation - Stock Titan
Zimmer Biomet (NYSE: ZBH) director receives stock and phantom unit awards - Stock Titan
Zimmer Biomet (ZBH) director Arthur Higgins receives new stock and phantom unit grants - Stock Titan
Zimmer Biomet (ZBH) director granted new RSUs and phantom stock awards - Stock Titan
Zimmer Biomet Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Zimmer Biomet (ZBH) Loses Ground as Stock Nears Key Support LevelGap and Reverse - thelegaladvocate.com
Is Zimmer Biomet Holdings (ZBH) One of the Best Robotic Surgery Stocks to Buy? - Insider Monkey
Zimmer Biomet Holdings, Inc. $ZBH Shares Purchased by Northwestern Mutual Wealth Management Co. - MarketBeat
Cast Saw Devices Market Size Forecast & Industry Trends 2035 - SNS Insider
Zimmer Biomet’s SWOT analysis: stock faces growth headwinds By Investing.com - Investing.com Australia
Zimmer Biomet’s SWOT analysis: stock faces growth headwinds - Investing.com
Morningstar Investment Management LLC Acquires 40,610 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: A Promising 15% Upside with Robust Revenue Growth - DirectorsTalk Interviews
PNC Financial Services Group Inc. Raises Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2026 - Sahm
Zimmer Biomet (ZBH) Declares Quarterly Dividend and Raises Share Repurchase Target - GuruFocus
Zimmer Biomet declares $0.24 quarterly dividend By Investing.com - Investing.com Nigeria
Zimmer Biomet declares $0.24 quarterly dividend - Investing.com UK
Zimmer Biomet Holdings, Inc. $ZBH Stake Cut by Heritage Investors Management Corp - MarketBeat
Zimmer Biomet Holdings, Inc. Stock 12‑Month Price Target Cut to $96.45, Implies 13% Upside - TradingView
Zimmer Biomet Holdings Inc Azioni (ZBH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.20%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):